Trial Profile
Evaluation of the antihypertensive effect of Hyzaar(R) [losartan hydrochlorothiazide] and cognitive function of hypertensive patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary) ; Indapamide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Organon
- 15 Dec 2006 New trial record.